Dea No. 9740 en es it fr

Dea No. 9740 Brand names, Dea No. 9740 Analogs

Dea No. 9740 Brand Names Mixture

  • No information avaliable

Dea No. 9740 Chemical_Formula


Dea No. 9740 RX_link

No information avaliable

Dea No. 9740 fda sheet

Dea No. 9740 msds (material safety sheet)

Dea_No._9740 MSDS

Dea No. 9740 Synthesis Reference

No information avaliable

Dea No. 9740 Molecular Weight

386.552 g/mol

Dea No. 9740 Melting Point

97 oC

Dea No. 9740 H2O Solubility

76 mg/L

Dea No. 9740 State


Dea No. 9740 LogP


Dea No. 9740 Dosage Forms

Liquid; Solution

Dea No. 9740 Indication

Used as an analgesic adjunct in anesthesia and as a primary anesthetic drug in procedures requiring assisted ventilation and in the relief of pain.

Dea No. 9740 Pharmacology

Sufentanil is a synthetic opioid analgesic. Sufentanil interacts predominately with the opioid mu-receptor. These mu-binding sites are discretely distributed in the human brain, spinal cord, and other tissues. In clinical settings, sufentanil exerts its principal pharmacologic effects on the central nervous system. Its primary actions of therapeutic value are analgesia and sedation. Sufentanil may increase the patient's tolerance for pain and decrease the perception of suffering, although the presence of the pain itself may still be recognized. In addition to analgesia, alterations in mood, euphoria and dysphoria, and drowsiness commonly occur. Sufentanil depresses the respiratory centers, depresses the cough reflex, and constricts the pupils.

Dea No. 9740 Absorption

No information avaliable

Dea No. 9740 side effects and Toxicity

LD50: 18.7 mg/kg (IV in mice)

Dea No. 9740 Patient Information

Dea No. 9740 Organisms Affected

Humans and other mammals